The global medicaldevice testing services market size is expected to reach USD
13.4 billion by 2025, according to a new report by Grand View Research, Inc.,
expanding at a CAGR of 11.5% during the forecast period. Increasing spending in
preclinical phase of medical devices coupled with growing outsourcing rate is
anticipated to help the market gain significant traction.
Surging demand for in-vitro test is also
projected to fuel demand for testing services as many CROs are developing novel
in-vitro methods to replace traditional in-vivo methods, which require animal
testing. Improvements in procedures for development and standardization of
novel in vitro test methods, particularly for sensitization, cytotoxicity, and
irritation, are also working in favor of the market.
There has been a significant increase in
preclinical spending for both pharmaceutical and medical devices. This trend is
estimated to contribute to the demand for testing services by medical device
companies.
Stringent regulatory standards pertaining
to user safety are supporting growing trend of outsourcing medical device
testing services. Increasing demand for good quality products is poised to
further trigger the demand for testing services by medical device companies.
These companies are constantly trying to comply with stringent regulatory norms
put forth by authorities across the globe.
A significant consolidation in the CRO
space has been observed in recent years. For instance, in October 2017,
Sterigenics International LLC acquired Toxikon Europe N.V., the European
division of Toxikon Corporation, to strengthen its preclinical service
portfolio for pharmaceutical and medical device companies.
Full research report on medical device testing
services market analysis:
https://www.grandviewresearch.com/industry-analysis/medical-device-testing-services-market
Further key findings from the report suggest:
·
The global biocompatibility testing market
is anticipated to reach USD 4.1 billion by 2025, at a CAGR of 11.3% from 2017
to 2025
·
In terms of service, the chemistry test
segment is likely to show the fastest growth during the forecast period
·
In terms of development phase, preclinical
testing held the largest market share in 2016. The segment will continue to
dominate the market throughout the forecast period, accounting for about two
third of the overall revenue by 2025.
·
Asia Pacific is expected to dominate the
medical device testing service market during the forecast period. The regional
market will post a CAGR of over 12.0% during the same period. Europe and North
America held remarkable cumulative share in 2016 owing to well established
manufacturing infrastructure for high end and complex medical devices
·
The market is partially consolidated and
competitive in nature. Some of the key companies present in the market are
Toxikon, Inc.; SGS SA; Eurofins Scientific, LLC; Intertek Group plc; WuXi
AppTec, Pace Analytical Services, NORTH AMERICAN SCIENCE ASSOCIATES INC.;
Sterigenics International LLC; Charles River Laboratories International Inc.;
American Preclinical Services; and Medical Device Testing Services.
View
more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global medical device testing
services market report on the basis of service, phase, and region:
Medical Device Testing Services Service
Outlook (Revenue, USD Million, 2014 - 2025)
·
Biocompatibility Tests
·
Chemistry Test
·
Microbiology & Sterility Testing
o
Bioburden Determination
o
Pyrogen & Endotoxin testing
o
Sterility Test & Validation
o
Antimicrobial Activity Testing
·
Package Validation
Medical Device Testing Services Phase
Outlook (Revenue, USD Million, 2014 - 2025)
·
Preclinical
·
Clinical
Medical Device Testing Services Regional
Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
France
o
Germany
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
Access Full Press Release of this
Report:
https://www.grandviewresearch.com/press-release/global-medical-device-testing-services-market
https://www.grandviewresearch.com/press-release/global-medical-device-testing-services-market
About Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment